Producer

Jiangsu Yangnong Chemical Group

HQ CN · Jiangsuwebsite ↗

Jiangsu Yangnong Chemical Group Co., Ltd. (Yangzhou, Jiangsu Province, China; SSE: 600486; ~¥8B revenue) is the largest identified Chinese generic producer of imidacloprid and a major manufacturer of acetamiprid and thiamethoxam technical grade. After Bayer's imidacloprid patents expired, Yangnong built large-scale generic capacity at its Yangzhou Jiangsu complex — producing technical grade AI for export to Asia, Africa, Latin America, and re-export through European and US formulators. China as a whole (including Yangnong, Shandong Sino-Agri United Biotechnology, Yancheng Limin Chemical, and 15-20 smaller producers) accounts for an estimated 50-60% of global neonicotinoid active ingredient by volume. Yangnong alone represents approximately 15-20% of global imidacloprid volume. Chinese generic neonicotinoids undercut originator prices by 60-80%, dominating developing-country markets and penetrating US generic supply chains.

2

Inputs supplied

2

Goods downstream

2

Facilities

0

Stories

What they make

2 inputs Jiangsu Yangnong Chemical Group supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Where it shows up

Goods downstream

Essential goods that depend on something Jiangsu Yangnong Chemical Group makes, pick one to see the full supply chain.

What else they do

Business segments

The company's full revenue map, where this supply-chain role fits within their broader business.

  • Neonicotinoid Insecticides (Technical AI)

    60%
  • Herbicides

    22%
  • Fungicides & Other AIs

    12%
  • Chemical Intermediates

    6%

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

  • Did you know2018

    Yangnong produces thiamethoxam (a neonicotinoid insecticide) that was banned in the EU in 2018 for outdoor agricultural use due to bee toxicity concerns, but remains approved and widely used in the US, Brazil, India, and Southeast Asia. Yangnong simultaneously sells thiamethoxam into markets where it's banned (EU, through formulation companies and re-export supply chains) for seed treatment uses that retain some exemptions, AND into markets where it's fully legal. The Chinese generic manufacturer produces the same molecule for two different regulatory contexts — effectively allowing markets with tighter regulations to access the substance through supply chain routing that bypasses the regulatory intent. Yangnong's thiamethoxam supply chain connects EU farmers trying to stay competitive with EU organic/environmental mandates to Chinese manufacturing operating under entirely different regulatory standards.

    European Commission
  • Concentration2022

    China's neonicotinoid industry is more concentrated than it appears from the outside: while there are nominally 15-20 Chinese generic neonicotinoid producers, approximately 70% of Chinese export volume is controlled by three companies — Jiangsu Yangnong Chemical, Shandong Sino-Agri United Biotechnology, and Yancheng Limin Chemical — all located in the Yangtze River Delta / Shandong manufacturing belt. Chinese regulators (MEE — Ministry of Ecology and Environment) have periodically ordered production suspensions at neonicotinoid facilities for environmental compliance failures — and these provincial-level enforcement actions have caused observable price spikes in global imidacloprid spot markets. In 2021, Chinese regulatory actions on chemical parks in Jiangsu Province for pollution control drove a 30-40% spike in generic imidacloprid prices globally within two months. This concentration of Chinese generic supply means that Chinese domestic regulatory and environmental policy — which is opaque to international observers — functions as a de facto price-setting mechanism for global generic neonicotinoid markets. Western buyers have no early-warning system for Chinese production curtailments.

    Agribusiness Global
  • Origin2023

    Jiangsu Yangnong Chemical was established in Yangzhou, Jiangsu Province in the early 1990s, positioned to exploit the expiration of Bayer's imidacloprid patents in China. Yangnong scaled up generic imidacloprid production rapidly after patent expiry, becoming the world's largest imidacloprid manufacturer by volume through cost advantages in Chinese specialty chemical manufacturing. The company subsequently expanded into generic acetamiprid and thiamethoxam production, building what is now the world's largest single-company portfolio of generic neonicotinoid technical active ingredients.

    Jiangsu Yangnong Chemical Group